Literature DB >> 9822131

Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants.

K Matsui1, X M Jin, M Kitagawa, A Miwa.   

Abstract

OBJECTIVE: To clarify the clinicopathologic features of neuroendocrine carcinomas (NECs) of the stomach, we reviewed 56 cases of surgically treated gastric carcinomas with a solid growth or with areas containing patterns characteristic for neuroendocrine (NE) tumors.
METHODS: Of the 56 cases reviewed, we selected 33 cases of NEC based both on histologic patterns common to NE tumors and on histochemical/immunohistochemical results.
RESULTS: The average age of patients with NEC was 69.8 years (range, 44-92 years). The majority of patients were men (male-female ratio, 23:10). The most frequently affected site was the upper third (46%) of the stomach. Grossly, 9 cases of NEC were fungating and 24 were ulcerated. As compared with 23 patients with non-NEC tumors, the patients with NECs had a worse prognosis. Histologically, NECs had a variety of histologic patterns, including solid, organoid, trabecular, pseudoglandular, spindle cell, and rosettelike. Based on both cell size and morphologic features, we subdivided NECs into 2 variants, namely, small cell NEC and large cell NEC. Our series included 12 cases of small cell NEC and 21 cases of large cell NEC.
CONCLUSIONS: Compared with small cell NECs, large cell NECs had a higher mitotic count, larger polygonal cells, a lower nuclear-cytoplasmic ratio, coarser nuclear chromatin, and more frequent conspicuous nucleoli. Large cell NEC was an aggressive tumor with a very poor prognosis (median survival time, 15.2 months; 1-year survival rate, 58%), which approached that for small cell NEC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822131

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  28 in total

1.  Simultaneous large cell neuroendocrine carcinoma and adenocarcinoma of the stomach.

Authors:  Tadashi Terada; Hirotoshi Maruo
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  Gastric adenocarcinoma? Looks similar but behaves differently!

Authors:  Tarun Rustagi; Mridula Rai; Todd J Alekshun
Journal:  J Gastrointest Cancer       Date:  2012-03

3.  Neuroendocrine gastric carcinoma expressing somatostatin: a highly malignant, rare tumor.

Authors:  Jaques Waisberg; Leandro Luongo de Matos; Ana Maria do Amaral Antonio Mader; Sergio Pezzolo; Esmeralda Miristene Eher; Vera Luiza Capelozzi; Manlio Basilio Speranzini
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

Review 4.  Management of primary gastric small cell carcinoma in China.

Authors:  Qin-Qin Wu; Wei-Guang Qiang; Feng Wang; Ke-Jun Dai; En-Ci Xu; Ju-Dong Luo; Qing Li; Hua Tang; Xi-Fa Zhou; Xu-Jing Lu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

5.  Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation.

Authors:  Olga Speck; Weihua Tang; Douglas R Morgan; Pei Fen Kuan; Michael O Meyers; Ricardo L Dominguez; Enrique Martinez; Margaret L Gulley
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015-10

6.  [Neuroendocrine neoplasia of the stomach : What is new?]

Authors:  T Knösel; C Reiter; G Schubert-Fritschle; A Altendorf-Hofmann; T Kirchner
Journal:  Pathologe       Date:  2017-03       Impact factor: 1.011

7.  Gastric mixed adenoneuroendocrine carcinoma with thyroid transcription factor-1-positive neuroendocrine component.

Authors:  Emi Yamaguchi; Yoshitoshi Sato; Takafumi Oe; Takeshi Nishi; Makoto Koike; Yasuhito Kitakado; Kenji Takubo
Journal:  Clin J Gastroenterol       Date:  2015-04-01

8.  Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases.

Authors:  Arvind Dasari; Kathan Mehta; Lauren A Byers; Halfdan Sorbye; James C Yao
Journal:  Cancer       Date:  2017-12-06       Impact factor: 6.860

9.  Gastric small cell carcinoma successfully treated by surgery and postoperative chemotherapy consisting of cisplatin and S-1: report of a case.

Authors:  Naohiko Koide; Akira Suzuki; Hiroyasu Saito; Toshiyuki Sato; Maki Murakami; Hiroyoshi Ota; Shinichi Miyagawa
Journal:  Surg Today       Date:  2007-10-25       Impact factor: 2.549

10.  Gastric carcinoma with osteoblastic differentiation.

Authors:  Fatih Selcukbiricik; Deniz Tural; Elif Tuba Senel; Sergülen Dervisoglu; Süheyla Serdengecti
Journal:  Int J Surg Case Rep       Date:  2012-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.